Design, synthesis and biological evaluation of (2S, 3R, 4R, 5S, 6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as potent and orally active SGLT dual inhibitors

被引：10

作者：

Xu, Guozhang ^{[1
]}

Gaul, Michael D. ^{[1
]}

Kuo, Gee-Hong ^{[1
]}

Du, Fuyong ^{[1
]}

Xu, June Zhi ^{[1
]}

Wallace, Nathaniel ^{[1
]}

Hinke, Simon ^{[1
]}

Kirchner, Thomas ^{[1
]}

Silva, Jose ^{[1
]}

Huebert, Norman D. ^{[1
]}

Lee, Seunghun ^{[1
]}

Murray, William ^{[1
]}

Liang, Yin ^{[1
]}

Demarest, Keith ^{[1
]}

机构：

[1] Janssen Res & Dev LLC, Discovery Sci & Cardiovasc & Metab Res, Welsh & McKean Rd, Spring House, PA 19477 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 21期

关键词：

Diabetes; Glucose transporter; SGLT1; inhibitor; SGLT2; Bioisostere; C-Aryl glucoside; AFFINITY NA+/GLUCOSE COTRANSPORTER; C-GLUCOSIDE; DISCOVERY; TRANSPORT; KIDNEY;

D O I：

10.1016/j.bmcl.2018.09.025

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of (2S, 3R, 4R, 5S, 6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as dual inhibitors of sodium glucose co-transporter proteins (SGLTs) were disclosed. Two methods were developed to efficiently synthesize C-5-fluoro-lactones 3 and 4, which are key intermediates to the C-5-fluoro-hexose based C-aryl glucosides. Compound 2b demonstrated potent hSGLT1 and hSGLT2 inhibition (IC50 = 43 nM for SGLT1 and IC50 = 9 nM for SGLT2). It showed robust inhibition of blood glucose excursion in oral glucose tolerance test (OGTT) in Sprague Dawley (SD) rats and exerted pronounced antihyperglycemic effects in db/db mice and high-fat diet-fed ZDF rats when dosed orally at 10 mg/kg.

引用

页码：3446 / 3453

页数：8

共 27 条

[11] Crystal and molecular structure of jatrophane diterpenoid (2R,3R,4S,5R,7S,8S,9S,13S,14S,15R)-2,3,8,9-tetraacetoxy-5,14-bis(benzoyloxy)-15-hydroxy-7-(isobutanoyloxy)jatropha-6(17),11 (E)-diene [J].

Yang, Hequn ;

Zhao, Jiangyu ;

Talipov, Samat ;

Izotova, Lidiya ;

Aisa, Haji Akber ;

Ibragimov, Bakhtiyar .

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2019, 75 :1884-+

[12] AN EFFICIENT SYNTHESIS OF (3S,5S)-5-[3,3-DIMETHYL-1-(o-TOLYL)-6-OXO-2H-PYRIDIN-4-YL]PIPERIDINE-3-CARBOXAMIDE AS POTENT RENIN INHIBITOR [J].

Mori, Yutaka ;

Iwamoto, Mitsuhiro ;

Mori, Kazuki ;

Yoshida, Masao ;

Honda, Takeshi ;

Nagayama, Takahiro ;

Nishi, Takahide .

HETEROCYCLES, 2014, 89 (06) :1413-1426

[13] An Efficient and Scalable Synthesis of (2R,αS)-3,4-Dihydro-2-[3-(1, 1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-α-(trifluoromethyl)-1(2H)-quinolineethanol: A Potent CETP Inhibitor [J].

Wang, Aihua ;

Zhang, Yan ;

Lu, Songfeng ;

Murray, William V. ;

Kuo, Gee-Hong .

JOURNAL OF HETEROCYCLIC CHEMISTRY, 2010, 47 (06) :1406-1410

[14] Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents [J].

Sudol-Talaj, Sylwia ;

Kucwaj-Brysz, Katarzyna ;

Podlewska, Sabina ;

Kurczab, Rafal ;

Satala, Grzegorz ;

Mordyl, Barbara ;

Gluch-Lutwin, Monika ;

Wilczynska-Zawal, Natalia ;

Jastrzebska-Wiesek, Magdalena ;

Czarnota-Lydka, Kinga ;

Kurowska, Kinga ;

Kubacka, Monika ;

Zeslawska, Ewa ;

Nitek, Wojciech ;

Olejarz-Maciej, Agnieszka ;

Doroz-Plonka, Agata ;

Partyka, Anna ;

Latacz, Gniewomir ;

Wesolowska, Anna ;

Handzlik, Jadwiga .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 260

[15] Design, Synthesis, and Biological Evaluation of 3,4-Dihydroisoquinolin-1(2H)-one Derivatives as Protein Arginine Methyltransferase 5 Inhibitors for the Treatment of Non-Hodgkin's Lymphoma [J].

Li, Qing-Qing ;

Quan, Xu ;

Wang, Zi-Xuan ;

Qiao, Nuo ;

Ni, Xing-Feng ;

Jing, Xiao-Long ;

Zhou, Shuang-Shuang ;

Tian, Xin-Lei ;

Zheng, Guo-Chuang ;

Zhan, Kang-Ning ;

Xu, Yu-Jing ;

Yang, Jin ;

Zhou, Yun ;

Liang, Xiao-Ting ;

Zhao, Zong-Hao ;

Wei, Tian-Hua ;

Liu, Qian ;

Bai, Ming-Yu ;

Sun, Shan-Liang ;

Yu, Yan-Cheng ;

Cao, Peng ;

Li, Nian-Guang ;

Zhang, Xiao-Meng ;

Liu, Jian ;

Shi, Zhi-Hao .

JOURNAL OF MEDICINAL CHEMISTRY, 2024, 68 (01) :108-134

[16] Synthesis and evaluation of anti-yellow fever virus activity of new 6-aryl-3-R-amino-1,2,4-triazin-5(4H)-ones [J].

Novodvorskyi, Yevhenii ;

Lesyk, Roman ;

Komarov, Igor ;

Lega, Dmitry ;

Zhuravel, Iryna ;

Moskalenko, Oleh ;

Sukhoveev, Volodymyr ;

Demchenko, Anatolii .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 248

[17] Preparation and pharmacological characterization of the enantiomers of the anticancer agent R / S- N-3-cyanophenyl- N '-(6-tert-butoxycarbonylamino-3,4-dihydro-2 , 2-dimethyl-2H-1-benzopyran-4-yl)urea: Identification of the R-enantiomer as the active eutomer [J].

Schnekenburger, Michael ;

Goffin, Eric ;

Schoumacher, Matthieu ;

Tumanov, Nikolay ;

Mouithys-Mickalad, Ange ;

de Tullio, Pascal ;

Wouters, Johan ;

Lebrun, Philippe ;

Diederich, Marc ;

Pirotte, Bernard .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2025, 13

[18] Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor [J].

Hao, Junliang ;

Beck, James P. ;

Schaus, John M. ;

Krushinski, Joseph H. ;

Chen, Qi ;

Beadle, Christopher D. ;

Vidal, Paloma ;

Reinhard, Matthew R. ;

Dressman, Bruce A. ;

Massey, Steven M. ;

Boulet, Serge L. ;

Cohen, Michael P. ;

Watson, Brian M. ;

Tupper, David ;

Gardiner, Kevin M. ;

Myers, Jason ;

Johansson, Anette M. ;

Richardson, Jeffery ;

Richards, Daniel S. ;

Hembre, Erik J. ;

Remick, David M. ;

Coates, David A. ;

Bhardwaj, Rajni M. ;

Diseroad, Benjamin A. ;

Bender, David ;

Stephenson, Greg ;

Wolfangel, Craig D. ;

Diaz, Nuria ;

Getman, Brian G. ;

Wang, Xu-shan ;

Heinz, Beverly A. ;

Cramer, Jeff W. ;

Zhou, Xin ;

Maren, Deanna L. ;

Falcone, Julie F. ;

Wright, Rebecca A. ;

Mitchell, Stephen N. ;

Carter, Guy ;

Yang, Charles R. ;

Bruns, Robert F. ;

Svensson, Kjell A. .

JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (19) :8711-8732

[19] A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660) [J].

Johnson, Christopher N. ;

Ahn, Jong Sook ;

Buck, Ildiko M. ;

Chiarparin, Elisabetta ;

Day, James E. H. ;

Hopkins, Anna ;

Howard, Steven ;

Lewis, Edward J. ;

Martins, Vanessa ;

Millemaggi, Alessia ;

Munck, Joanne M. ;

Page, Lee W. ;

Peakman, Torren ;

Reader, Michael ;

Rich, Sharna J. ;

Saxty, Gordon ;

Smyth, Tomoko ;

Thompson, Neil T. ;

Ward, George A. ;

Williams, Pamela A. ;

Wilsher, Nicola E. ;

Chessari, Gianni .

JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) :7314-7329

[20] Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies [J].

Burger, Matthew T. ;

Nishiguchi, Gisele ;

Han, Wooseok ;

Lan, Jiong ;

Simmons, Robert ;

Atallah, Gordana ;

Ding, Yu ;

Tamez, Victoriano ;

Zhang, Yanchen ;

Mathur, Michelle ;

Muller, Kristine ;

Bellamacina, Cornelia ;

Lindvall, Mika K. ;

Zang, Richard ;

Huh, Kay ;

Feucht, Paul ;

Zavorotinskaya, Tatiana ;

Dai, Yumin ;

Basham, Steve ;

Chan, Julie ;

Ginn, Elaine ;

Aycinena, Alex ;

Holash, Jocelyn ;

Castillo, Joseph ;

Langowski, John L. ;

Wang, Yingyun ;

Chen, Min Y. ;

Lambert, Amy ;

Fritsch, Christine ;

Kauffmann, Audry ;

Pfister, Estelle ;

Vanasse, K. Gary ;

Garcia, Pablo D. .

JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) :8373-8386

← 1 2 3 →